Insights from the STS/ACC TVT Transcatheter Valve Registry, presented at the American College of Cardiology (ACC) 2018 ...
March 15, 2018 – Johnson & Johnson Medical Devices Companies announced today that Biosense Webster, Inc., who works in ...
An economic analysis of the DEFINE-FLAIR study comparing FFR vs. iFR, found a cost savings of nearly $900. The late ...
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
March 15, 2018 — For people living with both Type 2 diabetes and heart failure, taking an aspirin each day appears to ...
March 15, 2018 – A newly-designed wristband and corresponding app that works with a smartwatch can accurately display ...
March 15, 2018 — For people with heart failure, getting a seasonal influenza (flu) vaccine in a given year was ...
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
March 15, 2018 — Women with normal blood pressure during pregnancy and who breastfed their babies for at least six ...
March 15, 2018 — Women diagnosed with preeclampsia during pregnancy were significantly more likely to develop high blood ...
March 14, 2018 — A late-breaking analysis of the landmark COMPASS study presented at the American College of Cardiology ...
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
The Zoll LifeVest is a temporary, wearable defibrillator designed as a safety net for patients, especially those being ...
After six months of follow-up, women newly diagnosed with breast cancer who were given the beta blocker carvedilol to prevent heart issues while undergoing chemotherapy showed no difference in declines in heart function compared with those taking a placebo. Patients who took carvedilol, however, were significantly less likely to have an elevated marker in the blood that signals injury to the heart, according to a study being presented at the American College of Cardiology’s (ACC) 67th Annual Scientific Session, March 10-12 in Orlando, Fla.
March 14, 2018 — Breast cancer patients who started taking one of two well-known heart medications at the same time they ...
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
March 13, 2018 – Among patients with persistently high cholesterol despite high-intensity statin therapy, the proprotein ...
March 13, 2018 – Wearing a lightweight vest equipped with a cardioverter defibrillator that detects abnormal heart ...
March 13, 2018 – HeartFlow, Inc. today announced that it has entered into a licensing and technology transfer agreement ...